ClinicalTrials.gov
ClinicalTrials.gov Menu

Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00952003
Recruitment Status : Active, not recruiting
First Posted : August 4, 2009
Last Update Posted : May 31, 2017
Sponsor:
Collaborators:
Pfizer
Sanofi
Roche Pharma AG
Information provided by (Responsible Party):
Arbeitsgemeinschaft medikamentoese Tumortherapie

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : October 22, 2014
  Estimated Study Completion Date : April 2018